Literature DB >> 8847588

Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan.

J Kuratsu1, Y Ushio.   

Abstract

This survey consists of 1117 residents of Kumamoto Prefecture who were diagnosed with primary intracranial tumors between 1989 and 1994. Age, sex, tumor type, and date of diagnosis were recorded in all cases; 79% of the diagnoses were confirmed histologically. The overall age-adjusted incidence rate was 9.47 per 100,000 population per year. Among males, the age-adjusted incidence rate was 8.24 per 100,000 per year, and the breakdown included 2.36 gliomas, 1.56 meningiomas, 1.46 pituitary tumors, and 0.99 neurinomas. Among females, the comparable overall rate was 10.7; that included a rate of 3.95 for meningiomas, 2.04 for gliomas, 2.16 for pituitary tumors, and 0.75 for neurinomas. Meningiomas were the most common tumor, with an average annual age-adjusted incidence of 2.76 per 100,000 population. The highest incidence of meniningiomas was 13.02 per 100,000 among women aged 70 to 79 years. The highest incidence of gliomas (5.71 per 100,000 males and 5.29 per 100,000 females) was seen in patients between 60 and 69 years of age. Meningiomas, pituitary adenomas, and malignant lymphomas occurred at a higher rate in females (male/female ratio: 0.39, 0.68, and 0.81, respectively). On the other hand, gliomas, neurinomas, and germ-cell tumors occurred more often in males (male/female ratio: 1.16, 1.32, and 4.29, respectively). Meningiomas and germ-cell tumors tended to exhibit gender specificity.

Entities:  

Mesh:

Year:  1996        PMID: 8847588     DOI: 10.3171/jns.1996.84.6.0946

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  20 in total

Review 1.  Stereotactic radiosurgery for benign meningiomas.

Authors:  Orin Bloch; Gurvinder Kaur; Brian J Jian; Andrew T Parsa; Igor J Barani
Journal:  J Neurooncol       Date:  2011-10-18       Impact factor: 4.130

Review 2.  Primary CNS germ cell tumors: current epidemiology and update on treatment.

Authors:  Jigisha P Thakkar; Lita Chew; J Lee Villano
Journal:  Med Oncol       Date:  2013-02-24       Impact factor: 3.064

3.  Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973-1993.

Authors:  Satoshi Kaneko; Kazuhiro Nomura; Takesumi Yoshimura; Naohito Yamaguchi
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

4.  Invasive intracerebral schwannoma mimicking meningioma in a child.

Authors:  Ruth E Bristol; Stephen W Coons; Harold L Rekate; Robert F Spetzler
Journal:  Childs Nerv Syst       Date:  2006-09-22       Impact factor: 1.475

5.  Neuro-Ophthalmic and Clinical Characteristics of Brain Tumours in a Tertiary Hospital in Ghana.

Authors:  N N Tagoe; V A Essuman; G Fordjuor; J Akpalu; P Bankah; T Ndanu
Journal:  Ghana Med J       Date:  2015-09

Review 6.  Practical guidelines for the treatment of malignant gliomas.

Authors:  M C Chamberlain; P A Kormanik
Journal:  West J Med       Date:  1998-02

7.  Unusual anatomic location of a primary intracranial yolk sac tumor.

Authors:  Anwar A Al-Masri; Nidal H Khasawneh; Tariq N Aladily
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

Review 8.  Intracranial meningiomas of atypical (WHO grade II) histology.

Authors:  Leland Rogers; Mark Gilbert; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-08-26       Impact factor: 4.130

9.  Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries.

Authors:  Bridget J McCarthy; Soichiro Shibui; Takamasa Kayama; Etsuo Miyaoka; Yoshitaka Narita; Michiko Murakami; Ayako Matsuda; Tomohiro Matsuda; Tomotaka Sobue; Bryan E Palis; Therese A Dolecek; Carol Kruchko; Herbert H Engelhard; J Lee Villano
Journal:  Neuro Oncol       Date:  2012-08-06       Impact factor: 12.300

10.  Incidence of first primary central nervous system tumors in California, 2001-2005.

Authors:  Monica Brown; Rudolph Schrot; Katrina Bauer; Deanna Letendre
Journal:  J Neurooncol       Date:  2009-04-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.